Publications
Events
Advertise
Subscribe
MyBN
Log In
Search
Menu
Close Navigation
Login
MyBN
Latest News
Resources
Property
Commercial Content
Back to previous menu
Close
Commercial Content
Announcements
Bulls N' Bears
Business Advice
Hearts & Minds
Industry Content
Skyline
Thought Leadership
All Categories
Back to previous menu
Close
All Categories
Resources
Property
Deals
Opinion
Government
Agribusiness
Education
Health
Infrastructure
Oil & Gas
Remuneration
Retail
Small Business
Technology, Innovation & Science
Tourism
Transport & Logistics
Explore All Categories
Data & Insights
Publications
Events
Advertise
Subscribe
Lists
Martin Rogers
Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN
Log In
Martin Rogers
Martin Rogers is a successful start-up investor and company director with experience in all aspects of financial, strategic and operational management. Mr Rogers had helped raised over $100m cash equity.
Lists and Charts
Total Shareholder Return
as at 29/02/24
Rank
Company
1 yr
5 yr
1331
st
Discovery Africa
-41%
4%
1514
th
Eastern Resources
-53%
11%
1765
th
OncoSil Medical
-72%
-44%
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Share Transactions
15/11/21
$29k Issued
Aeeris
28/05/21
$50k Issued
Aeeris
09/04/21
$0 Bought
Aeeris
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
Rank
Company
Revenue
970
th
OncoSil Medical
$1.5m
1201
st
Consolidated Financial Holdings
$0
1203
rd
Discovery Africa
$0
1209
th
Eastern Resources
$0
1210
th
3D Resources
$0
View Full List
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Show All Lists and Charts
Collapse All Lists and Charts
News Articles
Related Information
Positions
- Previous
Position
Company
Year
Company's current rank
Non-Executive Director (Chair 2013-2014)
OncoSil Medical
2013 - 2016
970
Executive Chairman
Actinogen Medical
2014 - 2016
867
Non-Executive Director
Zinc of Ireland
- 2008
578
Directors Interests
Company
Date
Transaction type
Number of shares
Price per share
Transaction value
Nature of change
Aeeris
15 Nov 2021
Issued
1,923,076
$0.02
$28,846
Rights issue
Aeeris
28 May 2021
Issued
1,923,076
$0.03
$50,000
Rights issue
Aeeris
09 Apr 2021
Bought
3,846,153
Placement
Aeeris
09 Apr 2021
Issued
15,384,615
Other
Issue of options: As per announcement on 12/04/2021.
View All
Powered by Morningstar ®
Equity Capital Markets Deals
Date
Company
Transaction Type
Total Value
24/04/15
Actinogen Medical
Placement
$10.0m
>>
View All
Subscribe today for award-winning, unbiased and trusted journalism
Subscription Options